TITLE

Consider the interplay of many complex factors in order to avoid or correct overtreatment in epilepsy

PUB. DATE
September 2006
SOURCE
Drugs & Therapy Perspectives;Sep2006, Vol. 22 Issue 9, p24
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Overtreatment in epilepsy is common, may arise in a wide variety of settings, and exposes the patient to excessive adverse effects and unnecessary treatment cost. A good understanding of the complex interplay of the heterogeneous nature of epilepsies, the available antiepileptic drugs and individual patient characteristics is essential to avoid or correct overtreatment
ACCESSION #
22027059

 

Related Articles

  • Anticonvulsant Action and Long-term Effects of Gabapentin. Cilio, M. R. // Current Neuropharmacology;Sep2003, Vol. 1 Issue 3, p203 

    Gabapentin (GBP), one of the newer antiepileptic drugs (AEDs), is a structural analogue of gamma-aminobutyric acid (GABA), initially approved for add-on treatment of partial seizures in patients 12 years and older and now widely used also in younger patients. Recent studies demonstrated its...

  • Isobolographic characterisation of interactions among selected newer antiepileptic drugs in the mouse pentylenetetrazole-induced seizure model. Luszczki, Jarogniew J.; Czuczwar, Stanislaw J. // Naunyn-Schmiedeberg's Archives of Pharmacology;Jul2005, Vol. 372 Issue 1, p41 

    The aim of this study was to characterise the types of interactions between gabapentin (GBP), tiagabine (TGB) and three second-generation antiepileptic drugs (AEDs) with different mechanisms of action (felbamate [FBM], loreclezole [LCZ], and oxcarbazepine [OXC]) by isobolographic analysis....

  • levetiracetam.  // Davis's Drug Guide for Nurses, 9th edition;2005, p609 

    Deals with the anticonvulsant drug levetiracetam. Indications; Pharmacokinetics; Adverse reactions and side effects.

  • tiagabine.  // Davis's Drug Guide for Nurses, 9th edition;2005, p1027 

    Deals with the anticonvulsant agent tiagabine. Indications; Pharmacokinetics; Adverse reactions and side effects.

  • Treatment of Grand Mal Epilepsy: Phenobarbital versus Diphenylhydantoin Sodium. Livingston, Samuel // Clinical Pediatrics;Aug1968, Vol. 7 Issue 8, p444 

    The author compares the effectiveness of phenobarbital and diphenylhydantoin sodium in the treatment of grand mal epilepsy. Both drugs possess significant anticonvulsive activity against grand mal epilepsy. Physicians who are treating epileptics encounter patients with grand mal seizures which...

  • Levetiracetam.  // Reactions Weekly;Nov2014, Vol. 1528 Issue 1, p132 

    The article presents a case study of a 19-year-old man who experienced creatine phosphokinase (CPK) elevation during treatment with levetiracetam.

  • Rufinamide.  // Reactions Weekly;1/9/2010 Part 1 of 2, Issue 1283, p82 

    The article describes the cases of 4 patients with generalised or mixed epilepsy syndromes who experienced seizure exacerbations during treatment with anticonvulsant rufinamide. The first patient is a 12-year-old boy with refractory childhood epilepsy. The second patient is a 4-year-old girl...

  • Correlation between Serum Level of Antiepileptic Drugs and their Side Effects. Hussein, Abbashar; Abdulgalil, Amira; Omer, Faroug; Eltoum, Hassan; Hamad, Ahmed; El-Adil, Omer; Mubarak, Bedraldin; Malkaldar, Mohmad; Idris, Iway; Alwidaa, Yasin; Mahmoud, Esam // Oman Medical Journal;Jan2010, Vol. 25 Issue 1, p1 

    Objectives: The aim of the study is to investigate the relation between serum levels of anticonvulsants and their side effects. Methods: This is a prospective cross sectional hospital based study conducted at Al Shaab Teaching Hospital. 120 patients were included in the study. The AEDs used were...

  • Pharmacology and Therapeutics of Gabapentin in the Treatment of Psychiatric Disorders; Present and Future Perspectives. Megna, J. L.; Iqbal, M. M.; Aneja, A. // Current Neuropharmacology;Sep2003, Vol. 1 Issue 3, p187 

    Gabapentin is an antiepileptic drug, which decreases neuronal excitability and may act by increasing the availability of gamma-aminobutyric acid or by inhibiting Ca2+ channels. It has safe pharmacokinetic and side effect profiles. Not surprisingly, it has been tested as a treatment in a number...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics